Brief: Nicox, Bausch Health: Vyzulta Gets Approved In South Korea

Nicox SA

09/02/2021 06:45

Feb 9 (Reuters) - Nicox SA  NCOX.PA :
    * BAUSCH HEALTH ANNOUNCES VYZULTA (LATANOPROSTENE BUNOD
OPHTHALMIC
SOLUTION), 0.024%, IS NOW APPROVED IN SOUTH KOREA
    * VYZULTA, 0.024%, HAS RECEIVED REGULATORY APPROVAL FROM
MINISTRY
OF FOOD AND DRUG SAFETY IN SOUTH KOREA

Source text for Eikon:  ID:nGNX7XcD0x 
Further company coverage:  NCOX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00 ;))